Hyperactivated NF-κB and AP-1 Transcription Factors Promote Highly Accessible Chromatin and Constitutive Transcription across the Interleukin-6 Gene Promoter in Metastatic Breast Cancer Cells

REFERENCES

• Agelopoulos, M., and D. Thanos. 2006. Epigenetic determination of a cell-specific gene expression program by ATF-2 and the histone variant macroH2A. EMBO J. 25:4843–4853.
   PubMed Web of Science ®Google Scholar
• Ancrile, B., K. H. Lim, and C. M. Counter. 2007. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev. 21:1714–1719.
   PubMed Web of Science ®Google Scholar
• Angelov, D., F. Lenouvel, F. Hans, C. W. Muller, P. Bouvet, J. Bednar, E. N. Moudrianakis, J. Cadet, and S. Dimitrov. 2004. The histone octamer is invisible when NF-kappaB binds to the nucleosome. J. Biol. Chem. 279:42374–42382.
   PubMedGoogle Scholar
• Apostolou, E., and D. Thanos. 2008. Virus infection induces NF-kappaB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression. Cell 134:85–96.
   PubMed Web of Science ®Google Scholar
• Armenante, F., M. Merola, A. Furia, and M. Palmieri. 1999. Repression of the IL-6 gene is associated with hypermethylation. Biochem. Biophys. Res. Commun. 258:644–647.
   PubMed Web of Science ®Google Scholar
• Armenante, F., M. Merola, A. Furia, M. Tovey, and M. Palmieri. 1999. Interleukin-6 repression is associated with a distinctive chromatin structure of the gene. Nucleic Acids Res. 27:4483–4490.
   PubMedGoogle Scholar
• Backdahl, L., A. Bushell, and S. Beck. 2009. Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. Int. J. Biochem. Cell Biol. 41:176–184.
   PubMed Web of Science ®Google Scholar
• Balch, C., K. P. Nephew, T. H. Huang, and S. A. Bapat. 2007. Epigenetic “bivalently marked” process of cancer stem cell-driven tumorigenesis. Bioessays 29:842–845.
   PubMed Web of Science ®Google Scholar
• Belguise, K., S. Guo, S. Yang, A. E. Rogers, D. C. Seldin, D. H. Sherr, and G. E. Sonenshein. 2007. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res. 67:11742–11750.
   PubMed Web of Science ®Google Scholar
• Belguise, K., N. Kersual, F. Galtier, and D. Chalbos. 2005. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24:1434–1444.
   PubMed Web of Science ®Google Scholar
• Bert, A. G., B. V. Johnson, E. W. Baxter, and P. N. Cockerill. 2007. A modular enhancer is differentially regulated by GATA and NFAT elements that direct different tissue-specific patterns of nucleosome positioning and inducible chromatin remodeling. Mol. Cell. Biol. 27:2870–2885.
   PubMedGoogle Scholar
• Bertucci, F., P. Finetti, J. Rougemont, E. Charafe-Jauffret, N. Cervera, C. Tarpin, C. Nguyen, L. Xerri, R. Houlgatte, J. Jacquemier, P. Viens, and D. Birnbaum. 2005. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res. 65:2170–2178.
   PubMed Web of Science ®Google Scholar
• Bosisio, D., I. Marazzi, A. Agresti, N. Shimizu, M. E. Bianchi, and G. Natoli. 2006. A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity. EMBO J. 25:798–810.
   PubMed Web of Science ®Google Scholar
• Brettingham-Moore, K. H., S. Rao, T. Juelich, M. F. Shannon, and A. F. Holloway. 2005. GM-CSF promoter chromatin remodelling and gene transcription display distinct signal and transcription factor requirements. Nucleic Acids Res. 33:225–234.
   PubMedGoogle Scholar
• Brettingham-Moore, K. H., O. R. Sprod, X. Chen, P. Oakford, M. F. Shannon, and A. F. Holloway. 2008. Determinants of a transcriptionally competent environment at the GM-CSF promoter. Nucleic Acids Res. 36:2639–2653.
   PubMedGoogle Scholar
• Cha, T. L., B. P. Zhou, W. Xia, Y. Wu, C. C. Yang, C. T. Chen, B. Ping, A. P. Otte, and M. C. Hung. 2005. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 310:306–310.
   PubMed Web of Science ®Google Scholar
• Dashwood, R. H., and E. Ho. 2007. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin. Cancer Biol. 17:363–369.
   PubMed Web of Science ®Google Scholar
• Dashwood, R. H., M. C. Myzak, and E. Ho. 2006. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis 27:344–349.
   PubMed Web of Science ®Google Scholar
• De Santa, F., M. G. Totaro, E. Prosperini, S. Notarbartolo, G. Testa, and G. Natoli. 2007. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130:1083–1094.
   PubMed Web of Science ®Google Scholar
• Dijsselbloem, N., S. Goriely, V. Albarani, S. Gerlo, S. Francoz, J. C. Marine, M. Goldman, G. Haegeman, and W. Vanden Berghe. 2007. A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to genistein. J. Immunol. 178:5048–5057.
   PubMed Web of Science ®Google Scholar
• Dijsselbloem, N., W. Vanden Berghe, A. De Naeyer, and G. Haegeman. 2004. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections: multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem. Pharmacol. 68:1171–1185.
   PubMed Web of Science ®Google Scholar
• Dong, J., E. Jimi, H. Zhong, M. S. Hayden, and S. Ghosh. 2008. Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms. Genes Dev. 22:1159–1173.
   PubMedGoogle Scholar
• Eferl, R., and E. F. Wagner. 2003. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3:859–868.
   PubMed Web of Science ®Google Scholar
• Espino, P. S., L. Li, S. He, J. Yu, and J. R. Davie. 2006. Chromatin modification of the trefoil factor 1 gene in human breast cancer cells by the Ras/mitogen-activated protein kinase pathway. Cancer Res. 66:4610–4616.
   PubMedGoogle Scholar
• Esteller, M. 2007. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8:286–298.
   PubMed Web of Science ®Google Scholar
• Finzer, P., U. Soto, H. Delius, A. Patzelt, J. F. Coy, A. Poustka, H. zur Hausen, and F. Rosl. 2000. Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: the role of the chromatin structure and AP-1 composition. Oncogene 19:3235–3244.
   PubMedGoogle Scholar
• Fischle, W., B. S. Tseng, H. L. Dormann, B. M. Ueberheide, B. A. Garcia, J. Shabanowitz, D. F. Hunt, H. Funabiki, and C. D. Allis. 2005. Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature 438:1116–1122.
   PubMed Web of Science ®Google Scholar
• Freund, A., V. Jolivel, S. Durand, N. Kersual, D. Chalbos, C. Chavey, F. Vignon, and G. Lazennec. 2004. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 23:6105–6114.
   PubMed Web of Science ®Google Scholar
• Fujioka, S., J. Niu, C. Schmidt, G. M. Sclabas, B. Peng, T. Uwagawa, Z. Li, D. B. Evans, J. L. Abbruzzese, and P. J. Chiao. 2004. NF-κB and AP-1 connection: mechanism of NF-κB-dependent regulation of AP-1 activity. Mol. Cell. Biol. 24:7806–7819.
   PubMed Web of Science ®Google Scholar
• Gerlo, S., G. Haegeman, and W. Vanden Berghe. 2008. Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells. Cell Signal. 20:1489–1496.
   PubMedGoogle Scholar
• Guo, L., J. Hu-Li, and W. E. Paul. 2005. Probabilistic regulation in TH2 cells accounts for monoallelic expression of IL-4 and IL-13. Immunity 23:89–99.
   PubMed Web of Science ®Google Scholar
• Hauser, A. T., and M. Jung. 2008. Targeting epigenetic mechanisms: potential of natural products in cancer chemoprevention. Planta Med. 74:1593–1601.
   PubMed Web of Science ®Google Scholar
• Heintzman, N. D., R. K. Stuart, G. Hon, Y. Fu, C. W. Ching, R. D. Hawkins, L. O. Barrera, S. Van Calcar, C. Qu, K. A. Ching, W. Wang, Z. Weng, R. D. Green, G. E. Crawford, and B. Ren. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39:311–318.
   PubMed Web of Science ®Google Scholar
• Hollander, G. A., S. Zuklys, C. Morel, E. Mizoguchi, K. Mobisson, S. Simpson, C. Terhorst, W. Wishart, D. E. Golan, A. K. Bhan, and S. J. Burakoff. 1998. Monoallelic expression of the interleukin-2 locus. Science 279:2118–2121.
   PubMedGoogle Scholar
• Holloway, A. F., S. Rao, X. Chen, and M. F. Shannon. 2003. Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins. J. Exp. Med. 197:413–423.
   PubMedGoogle Scholar
• Ichikawa, H., Y. Takada, S. Shishodia, B. Jayaprakasam, M. G. Nair, and B. B. Aggarwal. 2006. Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression. Mol. Cancer Ther. 5:1434–1445.
   PubMed Web of Science ®Google Scholar
• Inouye, S., M. Fujimoto, T. Nakamura, E. Takaki, N. Hayashida, T. Hai, and A. Nakai. 2007. Heat shock transcription factor 1 opens chromatin structure of interleukin-6 promoter to facilitate binding of an activator or a repressor. J. Biol. Chem. 282:33210–33217.
   PubMed Web of Science ®Google Scholar
• Ito, T., M. Yamauchi, M. Nishina, N. Yamamichi, T. Mizutani, M. Ui, M. Murakami, and H. Iba. 2001. Identification of SWI.SNF complex subunit BAF60a as a determinant of the transactivation potential of Fos/Jun dimers. J. Biol. Chem. 276:2852–2857.
   PubMedGoogle Scholar
• Jiang, C., and B. F. Pugh. 2009. Nucleosome positioning and gene regulation: advances through genomics. Nat. Rev. Genet. 10:161–172.
   PubMed Web of Science ®Google Scholar
• Johnson, B. V., A. G. Bert, G. R. Ryan, A. Condina, and P. N. Cockerill. 2004. Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization. Mol. Cell. Biol. 24:7914–7930.
   PubMedGoogle Scholar
• Kaileh, M., W. Vanden Berghe, A. Heyerick, J. Horion, J. Piette, C. Libert, D. De Keukeleire, T. Essawi, and G. Haegeman. 2007. Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J. Biol. Chem. 282:4253–4264.
   PubMed Web of Science ®Google Scholar
• Kirschmann, D. A., R. A. Lininger, L. M. Gardner, E. A. Seftor, V. A. Odero, A. M. Ainsztein, W. C. Earnshaw, L. L. Wallrath, and M. J. Hendrix. 2000. Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer. Cancer Res. 60:3359–3363.
   PubMed Web of Science ®Google Scholar
• Koga, K., G. Takaesu, R. Yoshida, M. Nakaya, T. Kobayashi, I. Kinjyo, and A. Yoshimura. 2009. Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity 30:372–383.
   PubMedGoogle Scholar
• Koutroubas, G., M. Merika, and D. Thanos. 2008. Bypassing the requirements for epigenetic modifications in gene transcription by increasing enhancer strength. Mol. Cell. Biol. 28:926–938.
   PubMed Web of Science ®Google Scholar
• Kouzarides, T. 2007. Chromatin modifications and their function. Cell 128:693–705.
   PubMed Web of Science ®Google Scholar
• Krappmann, D., E. Wegener, Y. Sunami, M. Esen, A. Thiel, B. Mordmuller, and C. Scheidereit. 2004. The IκB kinase complex and NF-κB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol. Cell. Biol. 24:6488–6500.
   PubMed Web of Science ®Google Scholar
• Lee, C. K., Y. Shibata, B. Rao, B. D. Strahl, and J. D. Lieb. 2004. Evidence for nucleosome depletion at active regulatory regions genome-wide. Nat. Genet. 36:900–905.
   PubMed Web of Science ®Google Scholar
• Lin, W. W., and M. Karin. 2007. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Investig. 117:1175–1183.
   PubMed Web of Science ®Google Scholar
• Lomberk, G., D. Bensi, M. E. Fernandez-Zapico, and R. Urrutia. 2006. Evidence for the existence of an HP1-mediated subcode within the histone code. Nat. Cell Biol. 8:407–415.
   PubMed Web of Science ®Google Scholar
• Lu, T., S. S. Sathe, S. M. Swiatkowski, C. V. Hampole, and G. R. Stark. 2004. Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancer. Oncogene 23:2138–2145.
   PubMed Web of Science ®Google Scholar
• Luo, J. L., W. Tan, J. M. Ricono, O. Korchynskyi, M. Zhang, S. L. Gonias, D. A. Cheresh, and M. Karin. 2007. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446:690–694.
   PubMed Web of Science ®Google Scholar
• Maniotis, A. J., K. Valyi-Nagy, J. Karavitis, J. Moses, V. Boddipali, Y. Wang, R. Nunez, S. Setty, Z. Arbieva, M. J. Bissell, and R. Folberg. 2005. Chromatin organization measured by AluI restriction enzyme changes with malignancy and is regulated by the extracellular matrix and the cytoskeleton. Am. J. Pathol. 166:1187–1203.
   PubMed Web of Science ®Google Scholar
• Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related inflammation. Nature 454:436–444.
   PubMed Web of Science ®Google Scholar
• Marban, C., S. Suzanne, F. Dequiedt, S. de Walque, L. Redel, C. Van Lint, D. Aunis, and O. Rohr. 2007. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J. 26:412–423.
   PubMed Web of Science ®Google Scholar
• Mateescu, B., P. England, F. Halgand, M. Yaniv, and C. Muchardt. 2004. Tethering of HP1 proteins to chromatin is relieved by phosphoacetylation of histone H3. EMBO Rep. 5:490–496.
   PubMed Web of Science ®Google Scholar
• Natoli, G., S. Saccani, D. Bosisio, and I. Marazzi. 2005. Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat. Immunol. 6:439–445.
   PubMed Web of Science ®Google Scholar
• Neve, R. M., K. Chin, J. Fridlyand, J. Yeh, F. L. Baehner, T. Fevr, L. Clark, N. Bayani, J. P. Coppe, F. Tong, T. Speed, P. T. Spellman, S. DeVries, A. Lapuk, N. J. Wang, W. L. Kuo, J. L. Stilwell, D. Pinkel, D. G. Albertson, F. M. Waldman, F. McCormick, R. B. Dickson, M. D. Johnson, M. Lippman, S. Ethier, A. Gazdar, and J. W. Gray. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515–527.
   PubMed Web of Science ®Google Scholar
• Ng, K. W., P. Ridgway, D. R. Cohen, and D. J. Tremethick. 1997. The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome. EMBO J. 16:2072–2085.
   PubMed Web of Science ®Google Scholar
• Ozanne, B. W., H. J. Spence, L. C. McGarry, and R. F. Hennigan. 2006. Invasion is a genetic program regulated by transcription factors. Curr. Opin. Genet. Dev. 16:65–70.
   PubMedGoogle Scholar
• Ozsolak, F., J. S. Song, X. S. Liu, and D. E. Fisher. 2007. High-throughput mapping of the chromatin structure of human promoters. Nat. Biotechnol. 25:244–248.
   PubMed Web of Science ®Google Scholar
• Pietersen, A. M., and M. van Lohuizen. 2008. Stem cell regulation by polycomb repressors: postponing commitment. Curr. Opin. Cell Biol. 20:201–207.
   PubMed Web of Science ®Google Scholar
• Ramirez-Carrozzi, V., A. Nazarian, C. Sarah, L. Gore, R. Sridharan, A. Imbalzano, and S. Smale. 2006. Selective and antagonistic functions of SWI/SNF and Mi-2[beta] nucleosome remodeling complexes during an inflammatory response. Genes Dev. 20:282–296.
   PubMed Web of Science ®Google Scholar
• Rieber, M., and M. Strasberg-Rieber. 2007 Different chromatin organization in benign and malignant cells revealed by unequal nuclease sensitivity between tumor and normal cell genomes. Am. J. Pathol. 170:787–789.
   PubMedGoogle Scholar
• Rosenfeld, M. G., V. V. Lunyak, and C. K. Glass. 2006. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20:1405–1428.
   PubMed Web of Science ®Google Scholar
• Schones, D. E., K. Cui, S. Cuddapah, T. Y. Roh, A. Barski, Z. Wang, G. Wei, and K. Zhao. 2008. Dynamic regulation of nucleosome positioning in the human genome. Cell 132:887–898.
   PubMed Web of Science ®Google Scholar
• Serra, C., D. Palacios, C. Mozzetta, S. V. Forcales, I. Morantte, M. Ripani, D. R. Jones, K. Du, U. S. Jhala, C. Simone, and P. L. Puri. 2007. Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol. Cell 28:200–213.
   PubMed Web of Science ®Google Scholar
• Shi, B., J. Liang, X. Yang, Y. Wang, Y. Zhao, H. Wu, L. Sun, Y. Zhang, Y. Chen, R. Li, Z. Zhang, M. Hong, and Y. Shang. 2007. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol. Cell. Biol. 27:5105–5119.
   PubMed Web of Science ®Google Scholar
• Sliva, D. 2008. Suppression of cancer invasiveness by dietary compounds. Mini Rev. Med. Chem. 8:677–688.
   PubMed Web of Science ®Google Scholar
• Song, L., J. Li, M. Hu, and C. Huang. 2008. Both IKKalpha and IKKbeta are implicated in the arsenite-induced AP-1 transactivation correlating with cell apoptosis through NF-kappaB activity-independent manner. Exp. Cell Res. 314:2187–2198.
   PubMedGoogle Scholar
• Srinivasan, S., R. S. Ranga, R. Burikhanov, S. S. Han, and D. Chendil. 2007. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res. 67:246–253.
   PubMed Web of Science ®Google Scholar
• Stan, S. D., E. R. Hahm, R. Warin, and S. V. Singh. 2008. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res. 68:7661–7669.
   PubMed Web of Science ®Google Scholar
• Stein, B., A. S. Baldwin, Jr., D. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:3879–3891.
   PubMed Web of Science ®Google Scholar
• Surh, Y. J. 2003. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer. 3:768–780.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., and N. Miyata. 2006. Epigenetic control using natural products and synthetic molecules. Curr. Med. Chem. 13:935–958.
   PubMedGoogle Scholar
• Tirosh, I., and N. Barkai. 2008. Two strategies for gene regulation by promoter nucleosomes. Genome Res. 18:1084–1091.
   PubMed Web of Science ®Google Scholar
• Vanden Berghe, W., K. De Bosscher, E. Boone, S. Plaisance, and G. Haegeman. 1999. The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J. Biol. Chem. 274:32091–32098.
   PubMed Web of Science ®Google Scholar
• Vanden Berghe, W., N. Dijsselbloem, L. Vermeulen, M. Ndlovu, E. Boone, and G. Haegeman. 2006. Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-κB gene expression by soy isoflavones does not require estrogenic activity. Cancer Res. 66:4852–4862.
   PubMed Web of Science ®Google Scholar
• Vanden Berghe, W., M. Ndlovu, R. Hoya-Arias, N. Dijsselbloem, S. Gerlo, and G. Haegeman. 2006. Keeping up NF-kB appearances: epigenetic control of immunity or inflammation triggered epigenetics. Biochem. Pharmacol. doi:10.1016/j.bcp.2006.07.012.
   PubMedGoogle Scholar
• Vanden Berghe, W., S. Plaisance, E. Boone, K. De Bosscher, M. L. Schmitz, W. Fiers, and G. Haegeman. 1998. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273:3285–3290.
   PubMed Web of Science ®Google Scholar
• Van Laere, S., I. Van der Auwera, G. G. Van den Eynden, S. B. Fox, F. Bianchi, A. L. Harris, P. van Dam, E. A. Van Marck, P. B. Vermeulen, and L. Y. Dirix. 2005. Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis. Breast Cancer Res. Treat 93:237–246.
   PubMedGoogle Scholar
• Van Lint, C., J. Ghysdael, P. Paras, Jr., A. Burny, and E. Verdin. 1994. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J. Virol. 68:2632–2648.
   PubMed Web of Science ®Google Scholar
• van't Veer, L. J., H. Dai, M. J. van de Vijver, Y. D. He, A. A. Hart, M. Mao, H. L. Peterse, K. van der Kooy, M. J. Marton, A. T. Witteveen, G. J. Schreiber, R. M. Kerkhoven, C. Roberts, P. S. Linsley, R. Bernards, and S. H. Friend. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536.
   PubMed Web of Science ®Google Scholar
• Verdin, E. 1991. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J. Virol. 65:6790–6799.
   PubMedGoogle Scholar
• Verdin, E., P. Paras, Jr., and C. Van Lint. 1993. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12:3249–3259.
   PubMed Web of Science ®Google Scholar
• Vermeulen, L., G. De Wilde, P. V. Damme, W. Vanden Berghe, and G. Haegeman. 2003. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22:1313–1324.
   PubMed Web of Science ®Google Scholar
• Vicent, G. P., C. Ballare, A. S. Nacht, J. Clausell, A. Subtil-Rodriguez, I. Quiles, A. Jordan, and M. Beato. 2006. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol. Cell 24:367–381.
   PubMed Web of Science ®Google Scholar
• Voncken, J. W., H. Niessen, B. Neufeld, U. Rennefahrt, V. Dahlmans, N. Kubben, B. Holzer, S. Ludwig, and U. R. Rapp. 2005. MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1. J. Biol. Chem. 280:5178–5187.
   PubMed Web of Science ®Google Scholar
• Wang, X., K. Belguise, N. Kersual, K. H. Kirsch, N. D. Mineva, F. Galtier, D. Chalbos, and G. E. Sonenshein. 2007. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat. Cell Biol. 9:470–478.
   PubMed Web of Science ®Google Scholar
• Wang, Y., J. G. Klijn, Y. Zhang, A. M. Sieuwerts, M. P. Look, F. Yang, D. Talantov, M. Timmermans, M. E. Meijer-van Gelder, J. Yu, T. Jatkoe, E. M. Berns, D. Atkins, and J. A. Foekens. 2005. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671–679.
   PubMed Web of Science ®Google Scholar
• Winters, M. 2006. Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern. Med. Rev. 11:269–277.
   PubMed Web of Science ®Google Scholar
• Wolter, S., A. Doerrie, A. Weber, H. Schneider, E. Hoffmann, J. von der Ohe, L. Bakiri, E. F. Wagner, K. Resch, and M. Kracht. 2008. c-Jun controls histone modifications, NF-κB recruitment, and RNA polymerase II function to activate the ccl2 gene. Mol. Cell. Biol. 28:4407–4423.
   PubMed Web of Science ®Google Scholar
• Zerbini, L. F., Y. Wang, J. Y. Cho, and T. A. Libermann. 2003. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res. 63:2206–2215.
   PubMed Web of Science ®Google Scholar
• Zhang, W., H. Deng, X. Bao, S. Lerach, J. Girton, J. Johansen, and K. M. Johansen. 2006. The JIL-1 histone H3S10 kinase regulates dimethyl H3K9 modifications and heterochromatic spreading in Drosophila. Development 133:229–235.
   PubMed Web of Science ®Google Scholar
• Zhou, Y., C. Yau, J. W. Gray, K. Chew, S. H. Dairkee, D. H. Moore, U. Eppenberger, S. Eppenberger-Castori, and C. C. Benz. 2007. Enhanced NFkappaB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer. BMC Cancer 7:59.
   PubMedGoogle Scholar